October 2025
1. HUANG J, Shadman M
   First-line Therapy: Time-Limited Venetoclax Doublet Therapy.
   Hematol Oncol Clin North Am. 2025;39:885-901.
   

   >> Share

   
   
2. BROWN JR
   Resistance to Bruton Tyrosine Kinase Inhibitors.
   Hematol Oncol Clin North Am. 2025;39:951-963.
   

   >> Share

   
   
3. THOMPSON PA, Parry EM
   Advances in the Understanding of Richter Transformation.
   Hematol Oncol Clin North Am. 2025;39:997-1012.
   

   >> Share

   
   July 2025
4. VAINER N, Katsimigas A, Rotbain EC, Niemann CU, et al
   Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 25:S0889-8588(25)00065.
   

   >> Share

   
   
5. SOUMERAI JD, Davids MS
   Triplet Therapies in Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 23:S0889-8588(25)00063.
   

   >> Share

   
   
6. VOM STEIN AF, Frenzel LP
   Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 22:S0889-8588(25)00085.
   

   >> Share

   
   
7. IATROU A, Agathangelidis A, Bordini J, Stamatopoulos K, et al
   Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00076.
   

   >> Share

   
   
8. KAGERER A, Thompson MC
   Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00080.
   

   >> Share

   
   
9. BROWN JR, Davids MS
   The Rapidly Evolving Landscape of the Biology and Therapy of Chronic Lymphocytic Leukemia.
   Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00086.
   

   >> Share

   
   
10. SWORDER B, Siddiqi T
    Immunotherapy in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 8:S0889-8588(25)00082.
    

    >> Share

    
    
11. BHAT SA, Woyach JA
    Frontline Treatment of Chronic Lymphocytic Leukemia with Continuous Bruton's Tyrosine Kinase Inhibitors: A Comprehensive Overview.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00078.
    

    >> Share

    
    
12. PEREZ-CASTRO A, Abruzzo LV, Oakes CC
    The Chronic Lymphocytic Leukemia Epigenome: A Powerful and Stable Framework for Understanding Biological and Clinical Heterogeneity.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00077.
    

    >> Share

    
    June 2025
13. VITALE C, Ferrario A, Zamprogna G, Coscia M, et al
    Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jun 30:S0889-8588(25)00064.
    

    >> Share

    
    December 2023
14. CUMMINS K, Gill S
    Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia.
    Hematol Oncol Clin North Am. 2023;37:1125-1147.
    

    >> Share

    
    August 2023
15. SHAH P, Jacobson C
    Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2023 Aug 31:S0889-8588(23)00104.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share